Security key
98420X103
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR)
CUSIP: 98420X103
Q3 2022 13F Holders as of 30 Sep 2022
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 94,372,096
- Total 13F shares
- 39,133,898
- Share change
- +23,133,859
- Total reported value
- $66,911,740
- Put/Call ratio
- 400%
- Price per share
- $1.71
- Number of holders
- 54
- Value change
- +$39,611,313
- Number of buys
- 29
- Number of sells
- 7
Report period
Q3 2022
Institutions
54
Top holders
10
XFOR full security history
Newer quarter: Q4 2022
Previous quarter: Q2 2022
X4 Pharmaceuticals, Inc SEC filings
X4 Pharmaceuticals, Inc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 98420X103
Recent filing periods:
Top shareholders of XFOR - X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC |
13F
|
Company |
3.2%
|
3,019,540
|
$2,914,000 | — | 30 Jun 2022 | |
| Tri Locum Partners LP |
13F
|
Company |
1.8%
|
1,738,300
|
$1,677,000 | — | 30 Jun 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.8%
|
1,679,748
|
$1,621,000 | — | 30 Jun 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.7%
|
1,633,204
|
$1,576,000 | — | 30 Jun 2022 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
1.5%
|
1,373,849
|
$1,326,000 | — | 30 Jun 2022 | |
| AXA S.A. |
13F
|
Company |
1.2%
|
1,150,467
|
$1,110,201 | — | 30 Jun 2022 | |
| AIGH Capital Management LLC |
13F
|
Company |
1.1%
|
997,719
|
$962,000 | — | 30 Jun 2022 | |
| BVF INC/IL |
13F
|
Company |
0.9%
|
847,879
|
$818,000 | — | 30 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.76%
|
715,175
|
$690,000 | — | 30 Jun 2022 | |
| New Leaf Venture Partners, L.L.C. |
13F
|
Company |
0.35%
|
335,000
|
$323,000 | — | 30 Jun 2022 | |
| SV Health Investors, LLC |
13F
|
Company |
0.33%
|
311,490
|
$300,000 | — | 30 Jun 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.29%
|
277,453
|
$268,000 | — | 30 Jun 2022 | |
| Sio Capital Management, LLC |
13F
|
Company |
0.29%
|
276,909
|
$267,000 | — | 30 Jun 2022 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.27%
|
250,144
|
$278,000 | — | 30 Jun 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
216,194
|
$209,000 | — | 30 Jun 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
189,548
|
$182,000 | — | 30 Jun 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
179,963
|
$174,000 | — | 30 Jun 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.15%
|
139,696
|
$135,000 | — | 30 Jun 2022 | |
| Cormorant Asset Management, LP |
13F
|
Company |
0.11%
|
103,980
|
$100,000 | — | 30 Jun 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.08%
|
77,687
|
$75,000 | — | 30 Jun 2022 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.07%
|
67,483
|
$65,000 | — | 30 Jun 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.07%
|
61,409
|
$59,000 | — | 30 Jun 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.06%
|
55,709
|
$54,000 | — | 30 Jun 2022 | |
| Minot Wealth Management LLC |
13F
|
Company |
0.06%
|
55,000
|
$53,000 | — | 30 Jun 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.06%
|
54,733
|
$53,000 | — | 30 Jun 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.05%
|
45,228
|
$44,000 | — | 30 Jun 2022 | |
| Bleichroeder LP |
13F
|
Company |
0.04%
|
35,730
|
$34,000 | — | 30 Jun 2022 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.03%
|
33,000
|
$32,000 | — | 30 Jun 2022 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
21,057
|
$20,000 | — | 30 Jun 2022 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
20,385
|
$20,000 | — | 30 Jun 2022 | |
| Private Advisor Group, LLC |
13F
|
Company |
0.01%
|
13,221
|
$13,000 | — | 30 Jun 2022 | |
| Veritable, L.P. |
13F
|
Company |
0.01%
|
12,637
|
$12,000 | — | 30 Jun 2022 | |
| Dynamic Advisor Solutions LLC |
13F
|
Company |
0.01%
|
10,100
|
$10,000 | — | 30 Jun 2022 | |
| Mayflower Financial Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,000 | — | 30 Jun 2022 | |
| MOODY LYNN LIEBERSON & WALKER, LLC |
13F
|
Company |
0.01%
|
10,000
|
$10,000 | — | 30 Jun 2022 | |
| Blue Trust, Inc. |
13F
|
Company |
0.01%
|
8,520
|
$15,000 | — | 30 Jun 2022 | |
| American Portfolios Advisors |
13F
|
Company |
0.01%
|
6,250
|
$6,031 | — | 30 Jun 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,639
|
$5,000 | — | 30 Jun 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
4,569
|
$5,000 | — | 30 Jun 2022 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
4,000
|
$3,860 | — | 30 Jun 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,672
|
$3,000 | — | 30 Jun 2022 | |
| Clearstead Advisors, LLC |
13F
|
Company |
0%
|
2,100
|
$2,000 | — | 30 Jun 2022 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,215
|
$1,000 | — | 30 Jun 2022 | |
| High Net Worth Advisory Group LLC |
13F
|
Company |
0%
|
1,100
|
$1,000 | — | 30 Jun 2022 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
9
|
$9 | — | 30 Jun 2022 | |
| Derek M. Meisner |
3/4/5
|
Chief Legal Officer |
—
class O/S missing
|
145,155
|
$130,640 | — | 17 Aug 2022 | |
| Diego Cadavid |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
104,107
|
$93,696 | — | 01 Mar 2022 | |
| Rene Russo |
3/4/5
|
Director |
—
class O/S missing
|
6,000
|
— | — | 02 Jun 2021 |
Institutional Holders of X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) as of Q3 2022
As of 30 Sep 2022,
X4 PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (XFOR) was held by
54 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,133,898 shares.
The largest 10 holders included
NEA Management Company, LLC, Bain Capital Life Sciences Investors, LLC, ORBIMED ADVISORS LLC, AXA S.A., VANGUARD GROUP INC, Point72 Asset Management, L.P., Tri Locum Partners LP, Sio Capital Management, LLC, AIGH Capital Management LLC, and Parkman Healthcare Partners LLC.
This page lists
54
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
44
Q3 2022 holders
54
Holder diff
10
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 Value $ | Q3 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.